ArticleCancer communications (London, England)2018

Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo.

Yan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.